PASG

Passage Bio, Inc.

3.975

+0.515+14.88%

After Hours: 3.970 -0.005 -0.13%17:27 11/06 EST

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE3.390/3.460

TODAY RANGE3.390-4.000

VOL22.04K

MARKET CAP12.79M

52 WEEK RANGE3.290-20.00

AVG VOL (3M)20.21K

% TURNOVER0.68%

TURNOVER--

P/E (TTM)-0.3513

% RANGE17.63%

EPS(TTM)-11.3161

P/E(FORWARD)-0.4064

P/B2.870

BVPS1.385

DIVIDEND--

P/S--

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP11.80M

SHARES OUTSTANDING3.22M

NEXT EARNINGS11/09-11/13

FREE FLOAT2.97M

LOT SIZE1

EX-DATE07/14/2025

News

Press Releases

Financial Reports

Profile

TipRanks·15h ago
Passage Bio Stockholders Approve Merger and Related Proposals
TipRanks·10/29 16:30
Passage Bio’s PBFT02 Trial Termination Raises New Questions for PASG Investors
TipRanks·09/03 10:32
Passage Bio Amends Remix Merger, Private Financing Terms
TipRanks·08/11 06:45
TD Cowen Sticks to Their Hold Rating for Passage Bio (PASG)
TipRanks·06/30 02:03
Major Investor Quietly Boosts Stake in Biotech Player
NASDAQ·06/26 14:33
Weekly Buzz: IONS, MRK Get FDA Approvals; ACHV Gets CRL; ADCT Cuts Jobs; TECH Acquired
NASDAQ·06/25 08:15
Passage Bio And Remix Therapeutics Enter All-Stock Merger Agreement; Stock Down
Dow Jones·06/24 22:43
Passage Bio Shares Slide on Merger with Remix Therapeutics
TipRanks·06/24 20:52
Passage Bio Merges with Remix Therapeutics in All-Stock Deal
TipRanks·06/24 20:40
Passage Bio trading resumes
Dow Jones·06/24 20:23
Passage Bio to Be Absorbed by Remix Therapeutics
TipRanks·06/24 20:15
Passage Bio, Remix Therapeutics to combine in all-stock transaction
TipRanks·06/24 20:05
Passage Bio trading halted, news pending
Dow Jones·06/24 20:05
Press Release: Passage Bio and Remix Therapeutics Announce Merger Agreement

Same Industry

Name/Symbol

Change%

Price

PASG

REGN

GRDX

BNTX

UTHR

VRTX

SIGA

MRNA

CRL

MEDP

TLPH

ICLR

CBPO

IQV

MOLN

ARCT

GILD

PRAH

INCY

APVO

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.